Hemophilia therapy: the future has begun
The success story of hemophilia care first began in the 1970s, when the availability of plasma-derived concentrates of coagulation factor VIII (FVIII) and factor IX (FIX) provided efficacious treatment of bleeding in patients with hemophilia A and B. This positive scenario was consolidated in terms...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ferrata Storti Foundation
2020-03-01
|
| シリーズ: | Haematologica |
| オンライン･アクセス: | https://haematologica.org/article/view/9274 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|